Hematopoietic progenitor cell counting for prediction of the yield of peripheral blood stem cell in mobilization and harvest
10.3760/cma.j.issn.1009-9921.2013.05.010
- VernacularTitle:外周血造血祖细胞检测对外周血干细胞动员采集的预测意义
- Author:
Zheng WEI
;
Zhimei WANG
;
Jingli ZHUANG
;
Feng LI
;
Yunfeng CHENG
;
Shanhua ZOU
- Publication Type:Journal Article
- Keywords:
Peripheral blood stem cell transplantation;
Hematopoietic stem cell mobilization;
Forecasting
- From:
Journal of Leukemia & Lymphoma
2013;22(5):286-290
- CountryChina
- Language:Chinese
-
Abstract:
Objective To evaluate a method of fast detection of the hematopoietic progenitor cell (HPC) in peripheral blood samples and explore for an appropriate cutoff value in prediction of adequate CD34+ cell in apheresis concentrate.Methods Peripheral blood samples and apheresis concentrate samples were collected from 27 auto-PBSCT patients receiving chemotherapy plus G-CSF mobilization (chemo group) and 17 patients receiving G-CSF alone (non-chemo group).CD34+ cell counts were determined by flow cytometry according to ISHAGE guideline and HPC counts were detected using Sysmex XE-2100 automatic hemocyte analyzer.The correlation between HPC and CD34+ cell counts in peripheral blood samples and apheresis concentrates were analyzed.Receiver operating characteristic (ROC) curves was used to determine the cutoff value in prediction of adequate CD34+ cell in apheresis concentrate.Results CD34+ cell counts in peripheral blood samples can be estimated by HPC counts (r =0.711,P =0.000,r =0.656,P =0.004).CD34+ cell counts =-0.829+0.648×HPC counts (in chemo group) or 45.033+0.460×HPC counts (in non-chemo group).HPC counts in the peripheral blood of auto-PBSCT patients were highly correlated with the CD34+ cell yield (r =0.602,P =0.001),CD34+ cell counts =1.106+0.046×HPC counts.When HPC in peripheral blood was ≥85/μl,the prediction of adequate CD34+ cells in the yield of apheresis (≥5×106/kg body weight) would have a sensitivity of 78 ％ and a specifity of 82 ％.Conclusion HPC counts in peripheral blood samples in auto-PBSCT patients can be used to determine the optimal time of apheresis and be used as a good marker to predict the stem cell in the yield.
